Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 272 entries
View as:

Treatments for Improving Mood in Depressed Teens-2

Phase: N/A Priority: Normal
NCT ID: NCT03831347 Org: User:
Start: 03/01/19 End: 08/29/19 Due: 08/29/20

Fractionated Gemtuzumab Ozogamicin Followed by Non-engraftment Donor Leukocyte Infusions for Relapsed/Refractory Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT03374332 Org: User:
Start: 12/31/19 End: 09/30/24 Due: 09/30/25

BrUOG-PA-209: Lapatinib and Gemcitabine for Metastatic Pancreaticobiliary Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00447122 Org: User:
Start: 03/31/07 End: 08/31/08 Due: 08/31/09

Pragmatic Trial of Video Education in Nursing Homes

Phase: N/A Priority: Normal
NCT ID: NCT02612688 Org: User:
Start: 03/01/16 End: 05/31/19 Due: 05/31/20

Improving Smoking Cessation Outcomes in Heavy Drinkers - 1

Phase: N/A Priority: Normal
NCT ID: NCT00107575 Org: User:
Start: 08/31/03 End: 04/30/08 Due: 04/30/09

Early Systemic Central Nervous System Prophylaxis in Diffuse Large B-cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT03719560 Org: User:
Start: 07/01/19 End: 12/31/25 Due: 12/31/26

Effectiveness of Interpersonal Psychotherapy (IPT) for Men and Women Prisoners With Major Depression

Phase: N/A Priority: Normal
NCT ID: NCT01685294 Org: User:
Start: 12/31/11 End: 10/31/14 Due: 10/31/15

Lenalidomide for Advanced Hepatocellular Cancer:A Phase II Trial

Phase: N/A Priority: Normal
NCT ID: NCT00717756 Org: User:
Start: 01/31/09 End: 01/31/14 Due: 01/31/15

Retention in PrEP Care for African American MSM in Mississippi

Phase: N/A Priority: Normal
NCT ID: NCT03256435 Org: User:
Start: 09/07/16 End: 05/31/21 Due: 05/31/22

Developing an Online Mindfulness-based Intervention to Reduce Minority Stress and HIV Risk Among Young Adult MSM - Aim 3

Phase: N/A Priority: Normal
NCT ID: NCT05855655 Org: User:
Start: 04/08/23 End: 09/30/24 Due: 09/30/25

Project 3, Study 2: Extended Exposure to Low Nicotine Content Cigarettes in People With Current Affective Disorders

Phase: N/A Priority: Normal
NCT ID: NCT02232737 Org: User:
Start: 10/07/16 End: 01/14/19 Due: 01/14/20

Investigating The Role of Noise Correlations in Learning

Phase: N/A Priority: Normal
NCT ID: NCT06673303 Org: User:
Start: 11/10/24 End: 05/31/25 Due: 05/31/26

First-Line FOLFOX-Bevacizumab for Advanced Colorectal Cancer With Wild-Type Ras

Phase: N/A Priority: Normal
NCT ID: NCT01057017 Org: User:
Start: 01/31/10 End: 12/31/11 Due: 12/31/12

Very Low-Nicotine Cigarettes in Smokers With SUD

Phase: N/A Priority: Normal
NCT ID: NCT01989507 Org: User:
Start: 04/30/14 End: 05/31/21 Due: 05/31/22

BrUOG 329 Onivyde & Metronomic Temozolomide in Recurrent Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT03119064 Org: User:
Start: 11/30/17 End: 10/08/21 Due: 10/08/22

TAS-116 Plus Palbociclib in Breast and Rb-null Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05655598 Org: User:
Start: 09/12/23 End: 08/05/24 Due: 08/05/25

Skills to Enhance Positivity in Suicidal Youth

Phase: N/A Priority: Normal
NCT ID: NCT04994873 Org: User:
Start: 10/04/21 End: 09/01/26 Due: 09/01/27

Assessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMA

Phase: N/A Priority: Normal
NCT ID: NCT05754190 Org: User:
Start: 06/20/23 End: 06/30/25 Due: 06/30/26

Effects of Topiramate on Adolescent Alcohol Use: Efficacy and Mechanisms

Phase: N/A Priority: Normal
NCT ID: NCT01641445 Org: User:
Start: 07/31/12 End: 04/12/17 Due: 04/12/18

Cannabis' Impact on Alcohol Consumption

Phase: N/A Priority: Normal
NCT ID: NCT05389930 Org: User:
Start: 03/16/23 End: 03/31/27 Due: 03/31/28

Schools Championing Safe South Africa

Phase: N/A Priority: Normal
NCT ID: NCT05869864 Org: User:
Start: 01/31/23 End: 04/22/25 Due: 04/22/26

Harambee: Integrated Community-based HIV/NCD Care & Microfinance Groups in Kenya

Phase: N/A Priority: Normal
NCT ID: NCT04417127 Org: User:
Start: 11/26/20 End: 04/30/25 Due: 04/30/26

Adjuvant Nivolumab & Low Dose Ipilimumab for Stage III & Resected Stage IV Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT02656706 Org: User:
Start: 07/31/16 End: 07/31/25 Due: 07/31/26

Trial for Harm Reduction With Incentives & Vaping E-cigarettes

Phase: N/A Priority: Normal
NCT ID: NCT06111053 Org: User:
Start: 11/01/23 End: 08/28/24 Due: 08/28/25

Small Monetary Incentives to Promote Exercise (Exercise4Good; EX4G)

Phase: N/A Priority: Normal
NCT ID: NCT03134040 Org: User:
Start: 05/31/16 End: 06/01/18 Due: 06/01/19